|
|
|||||||||||||||||||||||||||||||||||||||||||
Sexually transmitted diseases in pregnancy ABSTRACT Subject headings: SEXUALLY TRANSMITTED DISEASES; EXUDATES AND TRANSUDATES/microbiology; PREGNANCY COMPLICATIONS, INFECTIONS; PERINATAL CARE. The
spread of sexually transmitted diseases (STDs) throughout the world has become a challenge for public health. STDs are becoming more prevalent and causing health problems that affect men, women, children and even unborn
babies.1 Cervical cancer, dementia and death are the consequences of some STDs, which are also the main causes of infertility in men and women in many countries. Some STDs affect the fetus and the
newborn; the pregnancies of women who suffer from these diseases may end with the death of the fetus, the newborn or the birth of a child who is seriously ill.2 The propagation of STDs depends on the following factors:
One of the main problems of perinatal medicine is STDs, both because of their rapid dissemination and the high incidence of morbidity.3 Available evidence demonstrates the urgency of combining
strategies to prevent and cure STDs in order to minimize their dissemination. Health workers must develop specific actions including educational and advisory activities on the causes, symptoms and risks of these diseases – an
effort we hope to support with this study. Methods A study of 120 pregnant women receiving
follow-up at the outpatient service for pregnant women at term and in the perinatal care unit of the Eusebio Hernández Gyneco-Obstetric Teaching Hospital was made from November 1996 through February 1997. In the
outpatient service, a microbiology laboratory technician took the samples of vaginal exudate for simple and cultured swabs. The physicians took them in the perinatal care unit. Samples were taken regardless of
whether or not these pregnant women had symptoms of sexually transmitted diseases. The attending physicians were informed of positive results to help them determine appropriate therapy (Tables 1-5). Results Table 1
shows the high incidence of positive results for the simple vaginal swabs—93 cases (77%)—with only 27 cases (22.5%) negative. It also shows the results of Gram endocervical swabs, taken to investigate the possible presence of intracellular Gram-negative diplococcus (
Neisseria gonorroheae). Only two cases (1.7%) were positive. Table 1. Results of microbiological study
Table 2 shows the microorganisms found in simple vaginal swabs. There were 48 cases (40%) of
Candida S.P., 30 cases (25%) of bacterial vaginosis and only 15 cases (12.5%) of trichomoniasis. Table 2. Microorganisms found in simple swabs
Table 3 shows the results of the cultured vaginal and endocervical swabs. Thirty-three
cases (27.5%) were positive. Table 3. Results of cultured vaginal and endocervical swab samples
The bacteria most frequently found in cultured vaginal and endocervical swabs (Table 4) were E. coli
, with eleven cases (9.2%); coagulase-positive staphylococcus, with 8 cases (6.6%); and streptococcus, with 7 cases (5.8%). Two cases of Neisseria gonorroheae
(1.7%) were also found. The results were negative in 87 cases (72.5%). Table 4. Bacteria contained in cultured vaginal and endocervical swabs
Table 5 shows the microbiological results throughout the post-partum period. Of the women studied, 30.8% had complications after birth. The most frequent disorder found was endometriosis—24 cases (20%). Eighty-three women (69.2%) had a normal puerperium.
Table 5. Result of microbiological studies in puerperium evolution
Discussion
Sexually transmitted diseases spread so fast that the damage they cause to health are ever greater, and the literature has little information about these diseases in pregnancy.
Cervico-Vaginal Infections in Pregnant Women, a paper presented by Dr. Ana Bertha Álvarez Pineda, M.D. in a forum at the Eusebio Hernández Hospital in Havana in 1996,
showed that 60% of results were positive, while our study showed a 77% incidence (Table 1). The simple swabs (Table 2) had microorganisms such as Candida S.P. (40%),
bacterial vaginosis (25%) and trichomoniasis (12.5%). The literature reports that Candida S.P. is found in 20-25% of all cases. This disease has been considered an STD since 1967
and it is now accepted that at least 50% of the cases reported result from sexual intercouse.4 Bacterial vaginosis (BV) is the current name for a polymicrobian clinical syndrome
characterized by an abnormal vaginal secretion, presenting alterations in the vaginal ecosystem, and displacement of lactobacilli by anaerobic microorganisms. Its etiology is associated with anaerobic agents such as
Bacteroids, Prevotella, and Peptostreptococcus, as well as Mobiluncus curtissic and maulers, Mycoplasmas hominis and Ureaplasma ureliticum. This last is reported to be present in 40-80% of
pregnant women, whose children are usually infected, and there are indications that a causal relationship exists between this infection in newborns and the evolution of a
bronchopulmonary dysplasia, most frequent in less mature children5,6. In general, BV has a negative relation to pregnancy and shows a strong association with
chorioamnionitis, amnionitis, ovular infection, premature rupture of the ovular membranes, and premature birth. The baby is frequently infected. The literature reports that about 33% of the cases have BV7-9
. Our study showed 25%. Tropical countries report that 15-40% of women of reproductive age are infected with trichomonas7,8,10. Trichomoniasis is known to be one of the most common STDs among
women and can be asymptomatic in 50% of the cases. It is estimated that 180 million women in the world suffer from vaginitis due to trichomonas every year.4 Its frequent association with
Neisseria gonorroheae and other microorganisms of bacterial vaginosis must be taken into account. Neisseria gonorroheae was found in 1.7% of the cases studied (Table 4), a figure that
may seem small but, if 100,000 pregnant women are considered, this would mean 1700 cases—a result that is similar to that reported by Dr. Onelia Ferrer, M.D. The literature states3
that the frequency of these disorders among female adolescents is 510 cases out of 10,000. When the sample includes women of all ages, the percentage decreases; if the
sample includes only pregnant women, the incidence is even less11. Dr. Susana Fiorito, M.D. found a prevalence of 1% of gonorrhea among pregnant women, and it is noteworthy that she also found 7% of
Chlamydia trachomatis in the same group. (Ferrer O. personal communication, Provincial Center for Hygiene and Epidemiology, Havana, 1997.) (Fiorito S. Enfermedades de transmisión sexual en mujeres embarazadas.
Fifth Latin-American Tropical Medicine Congress, Cuba, March 1997). As shown in Table 4, the most frequently found bacterium in our patients was the E. coli (92%). The literature shows4
that the most frequently isolated germs are the Gram-negative aerobic, particularly the enterobacteria, and the most frequently found is the E. coli. Then
come the anaerobic (among the BV) and then the aerobic streptococcus and, among them, the beta-hemolytic group B streptococcus, whose relationship to dangerous perinatal affections is known.
Infection is still one of the main causes of death in childbirth in the world. The puerperal infection is polymicrobian and has special characteristics that differentiate it from other
infectious processes in other fields such as pediatrics, surgery and family medicine, because these patients are immunodepressed and the infection, in addition to being polymicrobian,
has an insidious beginning, with worse evolution and prognosis, and even obtaining a sample can prove difficult. In our study, we found large numbers of puerperal women with septic
complications (30.8%), and thus we propose that specialists in OB-GYN further study these topics, which we are sure will result in better outcomes for mothers and children in the
future, and to decreased maternal and perinatal morbimortality. References 1. Guerra Macedo C. Enfermedad y daño a la salud. Las condiciones de la salud en las Américas. OPS 1: 1994:188-196. 2. Perea JE. Enfermedades de transmisión sexual. Cap. 1. Ediciones Doyana, Barcelona. 1993:1-7.
3. Schwatch SK National Surveillance of antimicrobial resistance in Neisseria gonorroheae. Medical Aspect of Human Sexuality. Feb.1992: 19-20.
4. Obstetricia y Ginecología Infanto Juvenil: Su importancia. Ciudad de la Habana, Socudef. 1996:35-60. 5. Slavin MB, Single dose oral fluroconazol vs intravaginal terconazole in treatment of Candida Vaginalis.
J Fla Med Assoc 10:1992. 6. Remington Jack S. Klein Jerome Q. Infection diseases of the fetus and newborn infant. 4ta de Philadelphia: WB Saunders, 1995: 619-646.
7. López Kaufman C, Bagnati E, Trumper E. Vaginosis bacteriana. Revista de la Sociedad de Ginecología Infanto Juvenil. 2:1991.39-49. 8. Sweet R. Nuevos enfoques terapéuticos de la vaginosis bacteriana.
Am J Obstet Gynecol, 1993 (169):479-82. 9. Sobel JD. Bacterial Vaginosis: assessment and treatment. J Ann Intern Med 111:1989:551-3.
10. Hillier SL. The normal vaginal flora, H202 producing lactobacilli and bacterial vaginosis in pregnant women. Clin Infect Dis 4:1993-273-281. 11. Palomares JC. Perea ES. Resistencia en N. gonorroheae.
Enf Infec Microbiol Clin 1987:5:3-6. This article originally appeared in the Revista Cubana de Obstetricia y Ginecología, vol. 24, no.1, (pp. 28-33), January-April, 1998.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||
|
|
|
|
|
|||||||